Van Eck Associates Corp Dr Reddys Laboratories LTD Transaction History

Van Eck Associates Corp

  • $78.1 Billion
  • Q4 2024

A detailed history of Van Eck Associates Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Van Eck Associates Corp holds 5,838 shares of RDY stock, worth $80,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,838
Previous 823 609.36%
Holding current value
$80,038
Previous $64,000 43.75%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
BUY
$13.99 - $79.75 $70,159 - $399,946
5,015 Added 609.36%
5,838 $92,000
Q3 2024

Oct 29, 2024
BUY
$75.41 - $84.21 $24,282 - $27,115
322 Added 64.27%
823 $64,000
Q1 2024

Apr 30, 2024
BUY
$67.36 - $77.59 $11,047 - $12,724
164 Added 48.66%
501 $36,000
Q4 2023

Feb 05, 2024
BUY
$64.27 - $69.9 $2,120 - $2,306
33 Added 10.86%
337 $23,000
Q3 2023

Nov 08, 2023
BUY
$61.9 - $72.77 $11,080 - $13,025
179 Added 143.2%
304 $20,000
Q1 2023

May 03, 2023
SELL
$51.63 - $56.93 $103 - $113
-2 Reduced 1.57%
125 $7,000
Q4 2022

Feb 08, 2023
BUY
$51.15 - $57.45 $2,608 - $2,929
51 Added 67.11%
127 $7,000
Q3 2022

Oct 27, 2022
BUY
$49.9 - $57.32 $1,746 - $2,006
35 Added 85.37%
76 $4,000
Q2 2022

Aug 03, 2022
SELL
$49.62 - $58.13 $545 - $639
-11 Reduced 21.15%
41 $2,000
Q3 2021

Nov 03, 2021
BUY
$60.19 - $75.29 $1,203 - $1,505
20 Added 62.5%
52 $3,000
Q1 2020

May 12, 2020
BUY
$34.75 - $45.85 $1,112 - $1,467
32 New
32 $1,000
Q2 2019

Aug 07, 2019
SELL
$36.05 - $42.76 $61,753 - $73,247
-1,713 Closed
0 $0
Q1 2019

May 13, 2019
BUY
$35.77 - $40.57 $71 - $81
2 Added 0.12%
1,713 $69,000
Q4 2018

Feb 12, 2019
BUY
$31.89 - $38.44 $1,020 - $1,230
32 Added 1.91%
1,711 $65,000
Q3 2018

Nov 13, 2018
SELL
$29.25 - $36.73 $2,193 - $2,754
-75 Reduced 4.28%
1,679 $58,000
Q1 2018

May 11, 2018
BUY
$31.93 - $39.54 $1,341 - $1,660
42 Added 2.45%
1,754 $57,000
Q4 2017

Feb 12, 2018
SELL
$34.15 - $37.62 $853 - $940
-25 Reduced 1.44%
1,712 $64,000
Q3 2017

Nov 09, 2017
SELL
$30.11 - $37.72 $1,234 - $1,546
-41 Reduced 2.31%
1,737 $62,000
Q2 2017

Aug 11, 2017
BUY
N/A
1,778
1,778 $75,000

Others Institutions Holding RDY

# of Institutions
265
Shares Held
107M
Call Options Held
71K
Put Options Held
22.5K
View Full List

About DR REDDYS LABORATORIES LTD

RDY Quotes by TradingView
  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.28B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email